| |
Presentation |
Webcast |
|
December 8, 2020
InDex Pharmaceuticals R&D day
|
|
|
|
November 26, 2020
Presentation at Redeye Life Science Day
|
|
|
|
October 12, 2020
Presentation of CONDUCT study at UEGW and ACG
|
|
|
|
October 6, 2020
Interview with InDex about the publication of the phase IIb CONDUCT study results in the Lancet Gastroenterology and Hepatology
|
|
|
|
October 6, 2020
Redeye interviews CMO Dr Thomas Knittel about the publication of the CONDUCT study results in the Lancet Gastroenterology and Heptology
|
|
|
|
September 24, 2020
Interview with CEO Peter Zerhouni at Bolagsdagen Erik Penser Bank
|
|
|
|
September 24, 2020
Presentation at Bolagsdagen Erik Penser Bank
|
|
|
|
September 2, 2020
Interview with CEO Peter Zerhouni at Pareto Securities Healthcare Conference
|
|
|
|
June 2, 2020
Presentation at Redeye Growth Day 2020
|
|
|
|
May 4, 2020
Interview with CEO Peter Zerhouni in Nordic Life Science News
|
|
|
|
April 29, 2020
Interview with CEO Peter Zerhouni about the market research studies with physicians and patients
|
|
|
|
April 20, 2020
Teleconference – update on the phase III preparations
|
|
|
|
February 20, 2020
Interview with Professor Walter Reinisch on the results of the CONDUCT-study
|
|
|
|
February 20, 2020
CEO interview on the conclusions from the in-depth analysis of the CONDUCT study
|
|
|
SVE
ENG
